Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for rent coverage ratios, Medicare exposure, or operator EBITDAR hidden inside American Healthcare REIT’s dense reports? Investors usually start with the American Healthcare REIT insider trading Form 4 transactions or the latest American Healthcare REIT quarterly earnings report 10-Q filing, then realize hundreds of pages remain. Our platform maps that journey for you, surfacing lease terms, occupancy trends, and geographic diversification in seconds.
Every document—whether a fresh 8-K on a facility acquisition or a detailed proxy—lands here the moment EDGAR releases it. Stock Titan’s AI-powered summaries translate complex real-estate jargon into plain language, turning the American Healthcare REIT Form 4 insider transactions real-time feed, the American Healthcare REIT annual report 10-K simplified, and each American Healthcare REIT proxy statement executive compensation section into actionable insights. Need quick answers? Type natural questions like “understanding American Healthcare REIT SEC documents with AI” and our system highlights the exact paragraph.
From dividend sustainability to triple-net lease risk, we connect filing types to what matters. Scan an American Healthcare REIT 8-K material events explained alert before the market reacts, review the American Healthcare REIT earnings report filing analysis for quarter-over-quarter NOI shifts, or track American Healthcare REIT executive stock transactions Form 4 to spot insider sentiment. Real-time updates, comprehensive coverage, and AI explanations mean you spend minutes—not days—extracting insight from every SEC disclosure.
American Healthcare REIT (NYSE:AHR) filed a Form 4 reporting a routine insider transaction. Director Marvin R. O'Quinn was granted 3,042 shares of restricted common stock on June 25, 2025 upon his re-election to the board. The grant carries a cost basis of $0 and is scheduled to vest on June 25, 2026. Following the award, O'Quinn’s beneficial ownership increases to 18,062 shares. No shares were sold or disposed of, and the filing does not reference a Rule 10b5-1 trading plan. The disclosure represents typical board compensation and does not indicate any material change in insider sentiment or the company’s financial condition.
American Healthcare REIT (AHR) filed a Form 4 disclosing that director Scott A. Estes received 3,042 restricted common shares on June 25 2025 upon his re-election to the board.
The grant was made at $0 cost and will vest on June 25 2026. Following the award, Estes' direct ownership increased to 18,895 shares, implying the new grant represents roughly 19 % of his post-transaction holdings.
No derivative securities, sales, or open-market purchases were reported, and the filing contains no additional financial information or risk disclosures.
American Healthcare REIT (NYSE:AHR) filed a Form 4 disclosing that Non-Executive Chairman and Director Jeffrey T. Hanson received 3,042 restricted common shares on 25 Jun 2025 following his re-election to the board. The grant was made at $0 cost and will vest in full on 25 Jun 2026.
Post-transaction, Hanson holds 41,808 shares directly and 85,163 shares indirectly through family trusts, retirement accounts and pension plans, bringing his total reported beneficial ownership to roughly 126,971 AHR shares. The filing also notes that securities held by NCT-107, LLC—a charitable foundation in which Hanson lacks pecuniary interest—will no longer be included in his Section 16 reports.
Form 144 Notice filed by Stefan K.L. Oh, an officer of American Healthcare REIT, indicating a proposed sale of 3,860 shares of common stock with an aggregate market value of $138,689.80 on the NYSE. The sale is scheduled for June 27, 2025.
The securities were originally acquired through an open market purchase on February 2, 2015, with cash payment. The company's total shares outstanding are 159,496,793. The sale will be executed through Charles Schwab & Co.
Key points:
- Sale represents approximately 0.002% of total shares outstanding
- Average price per share: $35.93
- No other securities were sold by the officer in the past 3 months
- Officer confirms no knowledge of undisclosed material adverse information
American Healthcare REIT (NYSE:AHR) filed an 8-K disclosing results from its June 25, 2025 Annual Meeting.
- Nine directors were re-elected for one-year terms ending in 2026.
- Shareholders ratified Deloitte & Touche LLP as independent auditor for FY 2025 (138.4 M for / 1.1 M against).
- Say-on-pay for 2024 executive compensation passed (109.3 M for / 7.5 M against).
- The 2025 Manager Equity Plan was approved (112.6 M for / 4.3 M against).
No other matters were brought to a vote.
On June 20, 2025, American Healthcare REIT, Inc. (NYSE: AHR) filed a Form 8-K to announce its second-quarter 2025 cash distribution.
The board authorized a quarterly dividend of $0.25 per common share, equal to an annualized rate of $1.00. Shareholders of record at the close of business on June 30, 2025, will receive the payment on or about July 18, 2025, funded solely from legally available funds.
No additional financial results, transactions, or strategic updates were disclosed in this report.
FAQ
What is the current stock price of AMERICAN HEALTHCARE REIT (AHR)?
What is the market cap of AMERICAN HEALTHCARE REIT (AHR)?
What is the primary focus of American Healthcare REIT Inc?
How does the company generate its revenue?
What are the main business segments of American Healthcare REIT Inc?
What is the RIDEA structure?
How is American Healthcare REIT positioned within the healthcare real estate industry?
What value does American Healthcare REIT Inc offer to investors?
How does the company manage its portfolio risk?
What regions does American Healthcare REIT Inc operate in?
